Cerebral infarction misses the optimal time for thrombolysis, some patients can still recover.
The morbidity and mortality rate in the acute phase of cerebral infarction is 5-15%, and the disability rate of the surviving patients is 50%, which means that 50% of the patients get a good recovery.
Cerebral infarction, also known as ischemic stroke, is an anoxic necrosis of the brain that occurs because of a localized impairment of the blood supply to the brain tissue. Thrombolysis is one of the most important tools in the treatment of stroke and is indicated for patients between the ages of 18 and 80 years with onset within 4.5 hours of the onset of symptoms of persistent cerebral impairment, and brain CT is required to rule out intracranial hemorrhage.
There are contraindications to thrombolytic therapy, including a history of intracranial hemorrhage in the last three months, or a history of surgery for bleeding in other parts of the digestive tract or urinary tract, severe liver and kidney function impairment, diabetic patients are not suitable for thrombolytic therapy, and patients with cerebral infarction or myocardial infarction in the last three months are not suitable for thrombolytic therapy.
In other words, not all patients with cerebral infarction need thrombolytic therapy, and not all patients are suitable for thrombolytic therapy.
If the optimal period of thrombolysis is missed, anti-platelet aggregation drugs such as clopidogrel or aspirin can be used, and at the same time, atorvastatin can be used to stabilize blood lipids, while controlling blood pressure and blood sugar. At the same time, heparin or low molecular heparin can be used for anticoagulation, and after the condition is stabilized, active rehabilitation can be started.
Generally, after active treatment, some patients can get good recovery or even cured.